Use of direct oral anticoagulants in thromboembolic disease

Wilson, M. R. , Docherty, K. F. and Gardner, R. S. (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber, 27(8), pp. 15-22. (doi: 10.1002/psb.1487)

Full text not currently available from Enlighten.

Abstract

Direct oral anticoagulants (DOACs) offer several advantages over warfarin in the management of thromboembolic disease. This article discusses their indications, mode of action, side-effects and interactions.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Docherty, Dr Kieran and Wilson, Dr Matthew and Gardner, Professor Roy
Authors: Wilson, M. R., Docherty, K. F., and Gardner, R. S.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Prescriber
Publisher:Wiley
ISSN:0959-6682
ISSN (Online):1931-2253
Published Online:12 September 2016

University Staff: Request a correction | Enlighten Editors: Update this record